Exact Mass: 480.2081
Exact Mass Matches: 480.2081
Found 305 metabolites which its exact mass value is equals to given mass value 480.2081
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
1-[(4-Amino-3-methylphenyl)methyl]-5-(2,2-diphenylacetyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridine-6-carboxylic acid
Acevaltrate
Production by Valeriana subspecies Acevaltrate is found in tea, fats and oils, and herbs and spices. Acevaltrate is found in fats and oils. Acevaltrate is produced by Valeriana specie C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic Acevaltrate inhibits the Na+/K+-ATPase activity in the rat kidney and brain hemispheres with IC50s of 22.8 μM and 42.3 μM, respectively[1]. Acevaltrate inhibits the Na+/K+-ATPase activity in the rat kidney and brain hemispheres with IC50s of 22.8 μM and 42.3 μM, respectively[1].
1-alpha-Acevaltrate
Constituent of Valeriana species 1-alpha-Acevaltrate is found in tea, fats and oils, and herbs and spices. 1-alpha-Acevaltrate is found in fats and oils. 1-alpha-Acevaltrate is a constituent of Valeriana sp.
Tucatinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EH - Human epidermal growth factor receptor 2 (her2) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163760 - HER2-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159156 - HER2 Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
6,10,11-trihydroxy-8-(3-hydroxy-3-methylbutyl)-3,3-dimethyl-9-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one
8beta-hydroxy-teucrolivin B|8??-Hydroxy-teucrolivin B
(6aR)-3-(4-hydroxy-2-methyl-6-oxocyclohexenyl)-6a-methyl-9-(2-methyloctanoyl)-6aH-furo[2,3-h]isochromene-6,8-dione|cohaerin D
2,7,8-Trimethyl-3,6-dimethoxy-[1,3-methylenebis(9H-carbazole)]-4,5-diol
3,4-dihydro-3,6,7,11-tetrahydroxy-8,9-di(3-methyl-2-butenyl)-2,2-dimethyl-pyrano[2,3-c]xanthone
3,3,4,5-tetramethoxybibenzyl-4-O-beta-D-glucopyranoside
1,7-bis-(3,4-dihydoxyphenyl)-5-hydroxy-heptane-3-O-beta-D-xylopyranoside
1,3,7,8-tetrahydroxy-4,6,9-tris(3-methyl-2-buten-1-yl)-11H-dibenzo[b,e][1,4]dioxepin-11-one|oliveridepsidone A
1(O)-acetyl-8alpha-acetoxy-10beta-hydroxy-hirsutinolide 1(O)-isovalerate
(1R*,4R*,5R*,6R*,8S*,10R*)-1,4-Dihydroxy-5,13-diacetoxy-8-tiglyloxycadin-7(11)-en-6,12-olide
Acevaltrate
Acevaltrate is a fatty acid ester. Acevaltratum is a natural product found in Fedia cornucopiae, Plectritis macrocera, and other organisms with data available. C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic Acevaltrate inhibits the Na+/K+-ATPase activity in the rat kidney and brain hemispheres with IC50s of 22.8 μM and 42.3 μM, respectively[1]. Acevaltrate inhibits the Na+/K+-ATPase activity in the rat kidney and brain hemispheres with IC50s of 22.8 μM and 42.3 μM, respectively[1].
Ala Met Pro Tyr
Ala Met Tyr Pro
Ala Pro Met Tyr
Ala Pro Tyr Met
Ala Tyr Met Pro
Ala Tyr Pro Met
Cys Pro Val Tyr
Cys Pro Tyr Val
Cys Val Pro Tyr
Cys Val Tyr Pro
Cys Tyr Pro Val
Cys Tyr Val Pro
Phe Met Pro Ser
Phe Met Ser Pro
Phe Pro Met Ser
Phe Pro Ser Met
Phe Ser Met Pro
Phe Ser Pro Met
His His Ser Thr
His His Thr Ser
His Met Pro Pro
His Asn Asn Pro
His Asn Pro Asn
His Pro Met Pro
His Pro Asn Asn
His Pro Pro Met
His Ser His Thr
His Ser Thr His
His Thr His Ser
His Thr Ser His
Ile Met Met Ser
Ile Met Ser Met
Ile Ser Met Met
Leu Met Met Ser
Leu Met Ser Met
Leu Ser Met Met
Met Ala Pro Tyr
Met Ala Tyr Pro
Met Phe Pro Ser
Met Phe Ser Pro
Met His Pro Pro
Met Ile Met Ser
Met Ile Ser Met
Met Leu Met Ser
Met Leu Ser Met
Met Met Ile Ser
Met Met Leu Ser
Met Met Ser Ile
Met Met Ser Leu
Met Met Thr Val
Met Met Val Thr
Met Pro Ala Tyr
Met Pro Phe Ser
Met Pro His Pro
Met Pro Pro His
Met Pro Ser Phe
Met Pro Tyr Ala
Met Ser Phe Pro
Met Ser Ile Met
Met Ser Leu Met
Met Ser Met Ile
Met Ser Met Leu
Met Ser Pro Phe
Met Thr Met Val
Met Thr Val Met
Met Val Met Thr
Met Val Thr Met
Met Tyr Ala Pro
Met Tyr Pro Ala
Asn His Asn Pro
Asn His Pro Asn
Asn Asn His Pro
Asn Asn Pro His
Asn Pro His Asn
Asn Pro Asn His
Pro Ala Met Tyr
Pro Ala Tyr Met
Pro Cys Val Tyr
Pro Cys Tyr Val
Pro Phe Met Ser
Pro Phe Ser Met
Pro His Met Pro
Pro His Asn Asn
Pro His Pro Met
Pro Met Ala Tyr
Pro Met Phe Ser
Pro Met His Pro
Pro Met Pro His
Pro Met Ser Phe
Pro Met Tyr Ala
Pro Asn His Asn
Pro Asn Asn His
Pro Pro His Met
Pro Pro Met His
Pro Ser Phe Met
Pro Ser Met Phe
Pro Val Cys Tyr
Pro Val Tyr Cys
Pro Tyr Ala Met
Pro Tyr Cys Val
Pro Tyr Met Ala
Pro Tyr Val Cys
Ser Phe Met Pro
Ser Phe Pro Met
Ser His His Thr
Ser His Thr His
Ser Ile Met Met
Ser Leu Met Met
Ser Met Phe Pro
Ser Met Ile Met
Ser Met Leu Met
Ser Met Met Ile
Ser Met Met Leu
Ser Met Pro Phe
Ser Pro Phe Met
Ser Pro Met Phe
Ser Thr His His
Thr His His Ser
Thr His Ser His
Thr Met Met Val
Thr Met Val Met
Thr Ser His His
Thr Val Met Met
Val Cys Pro Tyr
Val Cys Tyr Pro
Val Met Met Thr
Val Met Thr Met
Val Pro Cys Tyr
Val Pro Tyr Cys
Val Thr Met Met
Val Tyr Cys Pro
Val Tyr Pro Cys
Tyr Ala Met Pro
Tyr Ala Pro Met
Tyr Cys Pro Val
Tyr Cys Val Pro
Tyr Met Ala Pro
Tyr Met Pro Ala
Tyr Pro Ala Met
Tyr Pro Cys Val
Tyr Pro Met Ala
Tyr Pro Val Cys
Tyr Val Cys Pro
Tyr Val Pro Cys
1-a-Acevaltrate
2-[4-(2,2-dicyanovinyl)-N-ethyl-3-methylanilino]-1-(phenoxymethyl)ethyl carbanilate
DIMETHYL 2-(3-FORMYL-4-((2-METHOXYETHOXY)METHOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)SUCCINATE
Tucatinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EH - Human epidermal growth factor receptor 2 (her2) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163760 - HER2-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159156 - HER2 Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
[3-(4-{[3,3-Bis(hydroxymethyl)azetidin-1-yl]methyl}phenoxy)azetidin-1-yl][5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methanone
N-[2-(cyclopentylamino)-1-(3,4-dimethoxyphenyl)-2-oxoethyl]-N-[(4-fluorophenyl)methyl]-1H-pyrazole-5-carboxamide
(2R,4S)-2-[2-[[(5R)-5-amino-5-carboxypentyl]amino]-2-oxo-1-[(2-phenylacetyl)amino]ethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3,5-dimethyl-4-isoxazolesulfonamide
2-fluoro-N-[(2R,3S)-4-[[(2S)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
2-fluoro-N-[(2R,3R)-4-[[(2S)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
2-fluoro-N-[(2S,3S)-4-[[(2R)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide
2-fluoro-N-[(2S,3R)-4-[[(2R)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3,5-dimethyl-4-isoxazolesulfonamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3,5-dimethyl-4-isoxazolesulfonamide
2-fluoro-N-[(2R,3R)-4-[[(2R)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3,5-dimethyl-4-isoxazolesulfonamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3,5-dimethyl-4-isoxazolesulfonamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3,5-dimethyl-4-isoxazolesulfonamide
2-fluoro-N-[(2S,3R)-4-[[(2S)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
2-fluoro-N-[(2R,3S)-4-[[(2R)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
2-fluoro-N-[(2S,3S)-4-[[(2S)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
PD 123177
9-[2,4-dihydroxy-6-methyl-3-(3-methylbut-2-en-1-yl)benzoyloxy]-1,4-dimethyl-11-methylidene-10-oxotricyclo[6.3.0.0²,⁶]undec-8-ene-4-carboxylic acid
(3r)-3,5,9-trihydroxy-2,2-dimethyl-11,11-bis(3-methylbut-2-en-1-yl)-3,4-dihydro-1,7-dioxatetraphene-10,12-dione
(1r,6r,7r,7as)-4-[(acetyloxy)methyl]-1-[(3-methylbutanoyl)oxy]-6,7a-dihydro-1h-spiro[cyclopenta[c]pyran-7,2'-oxiran]-6-yl 3-(acetyloxy)-3-methylbutanoate
(1r,2r,3s,4s,5r,8r,9r,10r,12z,14s,17r)-10-(acetyloxy)-4,5,9-trihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadeca-6,12-dien-2-yl acetate
6-[(4-hydroxy-3-methoxy-2-methyl-9h-carbazol-1-yl)methyl]-3-methoxy-1,2-dimethyl-9h-carbazol-4-ol
methyl 8-hydroxy-10-(hydroxymethyl)-3-methylidene-4,5-bis[(2-methylpropanoyl)oxy]-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
(1r,2s,4as,5r,6r,8r,8ar)-2-(acetyloxy)-5-[2-(furan-3-yl)ethyl]-4a,6,8-trihydroxy-5,6-dimethyl-7-oxo-tetrahydrospiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
(1r,2s,6r,7r,9s,12s,13s)-12-(acetyloxy)-13-(hydroxymethyl)-9-methyl-5-methylidene-4-oxo-3,14-dioxatricyclo[7.4.1.0²,⁶]tetradecan-7-yl (2z)-2-[(acetyloxy)methyl]but-2-enoate
(1s,3s,4s,7r,8r)-8-(2,4-dihydroxy-3,5-dimethylbenzoyl)-3-hydroxy-5-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-1,3-dimethyl-7-[(1e)-prop-1-en-1-yl]bicyclo[2.2.2]octane-2,6-dione
13-[(acetyloxy)methyl]-12-hydroxy-9-methyl-5-methylidene-4-oxo-3,14-dioxatricyclo[7.4.1.0²,⁶]tetradecan-7-yl 4-(acetyloxy)-2-methylbut-2-enoate
(1r,2s,3s,4r,6s,8s,11z)-3-(acetyloxy)-11-{2-[(1r)-1-(acetyloxy)-3,3-dimethylcyclohexyl]ethylidene}-10-oxo-5,7,9-trioxatricyclo[6.3.0.0²,⁶]undecan-4-yl acetate
(3s)-3,6,7,11-tetrahydroxy-2,2-dimethyl-8,9-bis(3-methylbut-2-en-1-yl)-3,4-dihydro-1,5-dioxatetraphen-10-one
2-(acetyloxy)-5-[2-(furan-3-yl)ethyl]-4a,6,8-trihydroxy-5,6-dimethyl-7-oxo-tetrahydrospiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
(3r)-3,6,8,12-tetrahydroxy-2,2-dimethyl-7,11-bis(3-methylbut-2-en-1-yl)-3,4-dihydro-1,10-dioxatetraphen-5-one
3,3,12,17,26-pentamethyl-4,18-dioxa-12,26-diazaheptacyclo[15.11.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0¹⁹,²⁸.0²⁰,²⁵]nonacosa-5(14),6,8,10,15,19(28),20,22,24-nonaene-13,27-dione
8β-hydroxy-teucrolivin b
{"Ingredient_id": "HBIN013674","Ingredient_name": "8\u03b2-hydroxy-teucrolivin b","Alias": "NA","Ingredient_formula": "C24H32O10","Ingredient_Smile": "CC(=O)OCC12C(C(=O)C(C(C1(CCC(C23CO3)OC(=O)C)O)(C)CCC4=COC=C4)(C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10760","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
acevaltrate
{"Ingredient_id": "HBIN014504","Ingredient_name": "acevaltrate","Alias": "NA","Ingredient_formula": "C24H32O10","Ingredient_Smile": "CC(C)CC(=O)OC1C2C(=CC(C23CO3)OC(=O)CC(C)(C)OC(=O)C)C(=CO1)COC(=O)C","Ingredient_weight": "480.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "534","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137706187","DrugBank_id": "NA"}
ailantinol g
{"Ingredient_id": "HBIN014946","Ingredient_name": "ailantinol g","Alias": "NA","Ingredient_formula": "C24H32O10","Ingredient_Smile": "CCC(C)(C(=O)OC1C2C(C(C3(C4C2(CO3)C(CC4(C)C5C(=CC(=O)O5)C)OC1=O)O)O)C)O","Ingredient_weight": "480.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "780","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10896127","DrugBank_id": "NA"}